Skip to main content
. 2022 Jun 20;13:908077. doi: 10.3389/fphar.2022.908077

TABLE 3.

Details of curcumin’s role in inflammatory bowel disease treatment in vitro.

Cell line Dose (μM) Effects on biomarkers Pathways involved Ref.
IEC-6, HT-29, CACO-2 0–150 NF-κB↓ the IκB/NF-κB pathway Jobin et al. (1999)
Colonic epithelial cells (CEC), peritoneal macrophage, young adult mouse colonocytes cells (YAMC) 50 PI3K activity↓AKT phosphorylation↓F-actin polymerization↓MIP-2↓KC↓IL-1β↓MIP-1α PI3K/AKT pathway Larmonier et al. (2011)
Colonic myofibroblasts (CMF) 0–30 p38 MAPK↓NF-κB (-)MMP-3↓IL-1β↓IL-10↑ MAPK p38 pathway Epstein et al. (2010b)
BM-derived dendritic cell (BMDC) 1–100 IL-10↑NF-κB↓IL-6↓TNF-α NF-κB pathway Cong et al. (2009)
T-84 cells, young adult mouse colonocytes cells (YAMC) 0–75 IFN- γ ↓CIITA↓ Jak-Stat signaling pathway Midura-Kiela et al. (2012)